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Abstract: 
 
Background: Signaling through the antigen receptors of human B and T cells and the high-
affinity IgE receptor FcϵRI of rodent mast cells is decreased by cross-linking these receptors to 
the low-affinity IgG receptor FcγRII. The inhibition is thought to involve the tyrosine 
phosphorylationof immunoreceptor tyrosine–based inhibitory motifs (ITIMs) in the FcγRIIB 
cytoplasmic tail, creating binding sites for SH2-containing protein (Src homology domain 
containing protein tyrosine phosphatase 1 and 2 [SHP-1, SHP-2]) and/or lipid (SH2 domain-
containing polyphosphatidyl-inositol 5-phosphatase) phosphatases that oppose activating signals 
from the costimulated antigen receptors. Objective: In human basophils and mast cells FcϵRI 
signaling generates mediators and cytokines responsible for allergic inflammation. We proposed 
to determine whether FcϵRI signaling is inhibited by FcγRII costimulation in human basophils 
and to explore the underlying mechanism as an approach to improving the treatment of allergic 
inflammation. Methods:FcγR expression on human basophils was examined using flow 
cytometryand RT-PCR analysis. FcγRII/FcϵRI costimulation was typically accomplished by 
priming cells with anti-dinitrophenol (DNP) IgE and anti-DNP IgG and stimulating with DNP-
BSA. Phosphatases were identified by Western blotting, and their partitioning between 
membrane and cytosol was determined by cell fractionation. Biotinylated synthetic peptides 
and phosphopeptides corresponding to the FcγRIIB ITIM sequence were used for adsorption 
assays. Results: We report that peripheral blood basophils express FcγRII (in both the ITIM-
containing FcγRIIB and the immunoreceptor tyrosine–based activation motif–containing 
FcγRIIA forms) and that costimulating FcγRII and FcϵRI inhibits basophil FcϵRI-mediated 
histamine release, IL-4 production, and Ca2+ mobilization. The inhibition of basophil FcϵRI 
signaling by FcγRII/FcϵRI costimulation is linked to a significant decrease in Syk tyrosine 
phosphorylation. Human basophils express all 3 SH2-containing phosphatases. Conclusions: 
Evidence that FcγRII/FcϵRI costimulation induces SHP-1 translocation from the cytosolic to 
membrane fractions of basophils and that biotinylated synthetic peptides corresponding to the 
phosphorylated FcγRIIB ITIM sequence specifically recruit SHP-1 from basophil lysates 
particularly implicates this protein phosphatase in the negative regulation of FcϵRI signaling by 
costimulated FcγRII. 
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Abbreviations 
BCR:  B-cell antigen receptor 
DNP:  Dinitrophenol 
ITAM:  Immunoreceptor tyrosine-based activation motif 
ITIM:  Immunoreceptor tyrosine-based inhibitory motif 
PMSF:  Phenylmethylsulfonyl fluoride 
PY: Phosphotyrosine 
SHIP:  SH2-containing inositol phospholipid 5-phosphatase 
SHP-1:  Src homology domain containing protein tyrosine phosphatase 1 
SHP-2:  Src homology domain containing protein tyrosine phosphatase 2 
TCR:  T-cell antigen receptor 
 
Signaling through members of the multichain immune recognition receptor family, which 
includes the B-cell antigen receptor (BCR), the T-cell antigen receptor (TCR), the high-affinity 
IgE receptor (FcϵR1), and the FcγR1 and FcγRIII classes of IgG receptors, is mediated by 
immunoreceptor tyrosine–based activation motifs (ITAMs) within receptor subunit cytoplasmic 
tails. ITAMs are 26- to 27-amino acid sequences consisting of dual YXXL sequences separated 
by approximately 10 amino acids.1 Receptor activation leads to tyrosine phosphorylation of 
ITAMs by Src kinase family members, creating binding sites for the tandem SH2 domains of 
Syk kinase family members and initiating downstream signaling events. Recently, a motif 
transmitting negative signals, the immunoreceptor tyrosine-based inhibitory motif (ITIM), was 
identified first in FcγRIIB and subsequently in a series of immune system receptors. ITIMs are 
generally defined as 13-amino acid sequences including a consensus I/VxYxxL sequence.2 
ITIM-containing receptors can be grouped into two major classes on the basis of extracellular 
domains that identify them as members of the Ig superfamily (eg, FcγRIIB isoforms, KIR, 
gp49B1, CD22, PIR-B, and ILT-2) or as C-type lectins (eg, Ly-49 and MAFA). The inhibitory 
function of ITIMs is generally attributed to the ability of phospho-ITIMs to recruit SH2 domain–
containing phosphatases, particularly the protein tyrosine phosphatases SHP-1 and SHP-2, and 
the SH2 domain–containing polyphosphatidlyinositol 5-phosphatase (SHIP).3 
 
To date, the negative regulation of signaling through ITAM-containing receptors by signals from 
co–cross-linked ITIM-containing FcγRIIB isoforms has been demonstrated in mouse and human 
B cells that naturally coexpress BCR and FcγRIIB1 and in T-cell and mast cell lines that express 
TCR or FcϵRI plus endogenous or transfected FcγRIIB1.4 Negative regulation by other ITIM-
containing receptors has been demonstrated in mouse and human B cells (inhibition of BCR 
signaling by co–cross-linked CD22 and PIR-B5), in human natural killer cells (inhibition of 
FcγRIII signaling by co–cross-linked KIR6), in mouse bone marrow–derived mast cells 
(inhibition of FcϵRI signaling by co–cross-linked gp497), and in the RBL-2H3 rat mast cell line 
(inhibition of FcϵRI signaling by a variety of co–cross-linked or coligated receptors, including 
endogenous MAFA8 and CD819 and transfected PIR-B cytoplasmic domain10 and ILT-211). 
 
Here we show that human basophils express FcγRII (CD32) in both the ITIM-containing 
FcγRIIB and the ITAM-containing FcγRIIA forms but not FcγRI (CD64) or FcγRIII (CD16); we 
demonstrate negative signaling between FcγRII and FcϵRI in these cells; and we link this 
negative signaling to changes in Syk activation and phosphatase distribution. 
 
Methods 
 
Antibodies 
 
Anti-FcϵRI α subunit mAb 22E7 (IgG1)12 was a gift from Dr J. Kochan (Hoffman-La Roche, 
Nutley, NJ). Affinity-purified rabbit polyclonal antiphosphotyrosine (anti-PY) antibodies were 
prepared as described previously.13 Monoclonal anti-Lyn, anti-SHIP, anti-SHP-1, and anti-SHP-
2 (SH-PTP1 and SH-PTP2) were from Santa Cruz Biotechnology (Santa Cruz, Calif). 
Nonspecific mouse IgG1 (MOPC31C), anti-CD16 (IgG1), and FITC anti-PY mAbs were from 
Sigma (St Louis, Mo). The anti-FcγRII mAb AT10 recognizing all FcγRII isoforms (anti-CD32; 
IgG1) was from Serotec Ltd (Oxford, England). FcγRII expression was also probed with mAb IV 
(IgG1; A gift from Dr Carolyn Mold, University of New Mexico) specific for the FcγRIIA 
isoform.14 Anti-FcγRI (anti-CD64; IgG1) antibodies were from Biosource (Camarillo, Calif). 
Monoclonal anti-Syk (IgG2a) was from Zymed Labs (San Francisco, Calif). Anti-F(ab′)2 FITC 
anti-mouse and anti-rabbit antibodies were from Jackson Labs (West Grove, Pa). Anti-4-
hydroxyl-3-nitro-phenacetyl IgE (obtained from the cell line JW8 (ECACC #87080706) and 
NIP-(4-hydroxyl-3-nitro-5-iodo-phenylacetyl) were gifts from Graham Mackay (University of 
New Mexico). 
 
Antidinitrophenol (anti-DNP) IgE mAb was prepared as described previously.15 Hybridomas 
secreting anti-DNP IgG mAbs were obtained by the fusion of spleen cells of a BALB/c mouse 
immunized subcutaneously 6 times with DNP26-ovalbumin (10 μg per immunization emulsified 
with Freund's adjuvant) with mouse myeloma cells. Four weeks after the last immunization, a 
final boost of 10 μg of the same antigen (without adjuvant) was given intraperitoneally. Three 
days later, spleen cells were fused with SP2/0-Ag14 mouse myeloma cells by using 
polyethyleneglycol.16 Hybridomas secreting DNP-specific antibodies were selected by means of 
ELISA assays with plates that had been coated with bovine albumin and derivatized in situ with 
2,4,6-trinitrobenzene sulfonic acid in borate buffer. After incubating culture supernatants for 2 
hours at 37°C, binding was revealed by using anti-mouse IgG coupled to alkaline phosphatase 
(Zymed Labs). Selected hybridomas were cloned by means of limiting dilution and repeat 
ELISA. Isotypes were determined with a commercial kit (Mouse Monoclonal Antibody 
Isotyping Kit, Sigma). Cloned hybrids were grown as ascitic fluid in the peritoneal cavity of 
BALB/c mice injected 10 days earlier with Pristane (Sigma). The antibodies were purified from 
clarified ascitic fluid by using affinity chromatography on columns with DNP-BSA coupled to 
cyanogen bromide–activated Sepharose 4B. Antibodies were eluted with 0.1 mol/L 2,4-DNP and 
passed through a Dowex 1X8-400 column, and fractions containing antibodies (detected by UV 
absorbance) were pooled and tested by means of flow cytometry for binding to acid-stripped 
basophils. 
 
Isolation of basophils 
 
Venous blood (50-150 mL) was collected from normal donors after informed consent was 
obtained. Basophils were enriched to 15% to 65% purity by using Percoll gradient 
centrifugation.17 Contaminating cells were removed by negative selection with an mAb cocktail 
for human basophil enrichment (StemCell Technologies, Vancouver, British Columbia, Canada) 
and magnetic bead separation (Miltenyi Biotec, Auburn, Calif).18 In some experiments 
negatively selected basophils (>90% pure) were flow sorted (95 to >99.9% purity) on the basis 
of forward- and side-scatter characteristics.17 
 
Fcγ receptor analysis by flow cytometry 
 
To detect FcγR classes, Percoll-enriched basophils were incubated for 30 minutes at 4°C in PBS-
BSA with 10 μg/mL mouse mAbs to human FcγRI (CD64), FcγRII (CD32), and FcγRIII (CD16) 
and then washed and incubated for another 30 minutes at 4°C with a 1:200 dilution of 
F(ab′)2 FITC goat anti-mouse antibodies. To identify mouse anti-DNP mAbs that bound in a 
stable fashion to basophil FcγRII, acid-stripped basophils19 were incubated with 5 μg/mL DNP-
specific mAbs for 1 to 3 hours at 4°C and then washed and incubated for 30 minutes at 4°C with 
a 1:200 dilution of F(ab′)2 FITC goat anti-rabbit antibodies. Washed cells were resuspended in 
400 μL of PBS-BSA for flow cytometry. Basophils were identified on the basis of their forward- 
and side-scatter pattern, as described previously,17and mean channel fluorescence was 
determined for at least 10,000 cells by using a Coulter Epics Elite flow cytometer. MOPC31C 
nonspecific mouse IgG1 or nonimmune rabbit IgG were used as negative controls. 
 
Fcγ receptor analysis by RT-PCR and Southern blotting 
 
Total cellular RNA was extracted using the Micro-FastTrack Method (Invitrogen, San Diego, 
Calif) from 4 × 105 positively selected flow-sorted basophils and from the monocyte-lymphocyte 
cell population (PBL-no basophils) obtained after Percoll gradient centrifugation. RNA was 
concentrated by ethanol precipitation, resuspended in diethylpyrocarbonate-treated water, and 
stored at –70°C. Complementary (c)DNA was synthesized from 20 μL of RNA by using a first-
strand cDNA kit (Pharmacia Biotech, Piscataway, NJ). FcγRII isoforms were specifically 
amplified by using 3 sets of primers: STB and C2-ac (IIA-specific); STC and C2-b (IIB-
specific); and STC and C2-ac (IIC-specific). STC has been previously described.20 New primers 
included the following: 5′-CCAACTTTGTCAGCCTCAT-3′(C2-b), a 3′-end primer located in 
the C2 exon specific for the FcγRIIB isoform; 5′-TCAAAT-GGGCAGCCTTCA-3′ (C2-ac), a 3′-
end primer located in the C2 exon specific for both FcγRIIA and FcγRIIC isoforms; and 5′-
CAGAATGTATGTCCCAGAA-3′ (STB), a 5′-end primer for the start of the IIA isoform. Actin 
primers were as follows: 5′-TTCTACAATGAGCTGCGTGTG and 3′-
CACTGTGTTGGCATAGAGGTC. PCR amplification conditions consisted of one cycle with a 
denaturing step at 94°C for 2 minutes, annealing at 52°C for 2 minutes, and an extension at 72°C 
for 5 minutes followed by 40 cycles of a denaturing step at 94°C for 1 minute, annealing at 52°C 
for 1 minute, and extension at 72°C for 1 minute. The last cycle was followed by a 15-minute 
extension step at 72°C. Southern blot analysis of PCR products was performed by using a 
digoxygenin-uridine 5′-triphosphate (Boehringer Mannheim, Indianapolis, Ind) RS91-46 probe, 
as previously described.20 
 
Cell activation 
 
Untreated or acid-stripped Percoll-enriched basophils were suspended in fresh Iscove's medium 
(Iscove's modified Dulbecco's medium containing 5% heat-inactivated FBS, nonessential amino 
acids, and 5 μg/mL gentamicin) and primed in 5-mL tubes with 10 μg/mL mouse anti-DNP IgE 
(or anti-NP-IgE), mouse anti-DNP IgG, or a combination of both for 2 hours at 37°C in a 5% 
CO2 incubator. Cells were washed with HBSS=(HBSS without Ca2+ or Mg2+),18 resuspended to 
0.5 to 1.1 × 106basophils/mL in prewarmed HBSS+ (HBSS with 1.4 mmol/L CaCl2 and 1 
mmol/L MgCl2) with DNP-BSA (0.005-0.01 μg/mL) or NIP-BSA (0.001-1 μg/mL), and 
activated by incubation at 37°C for 45 minutes (his-tamine) or 4 hours (IL-4) at 37°C in a 5% 
CO2 incubator. Reactions were stopped by centrifugation at 150g at 4°C. Supernatants were 
stored at –70°C. Histamine release was measured as previously described.18 IL-4 was measured 
in the supernatants by using a kit from Biosource. 
 
Ca2+ mobilization 
 
Percoll-enriched negatively selected basophils were transferred to poly-L -lysine–coated glass 
coverslips and loaded with 2 μmol/L Fura-2AM (Sigma), as previously described,21 during the 
last 30 minutes of priming with anti-DNP IgE and anti-DNP-IgG. Washed coverslips were 
transferred to a temperature-controlled dish with a 5% CO2 atmosphere and mounted on the stage 
of an inverted Zeiss fluorescence microscope. The microscope is equipped with a 100-W Hg 
lamp and computer-controlled filter wheels and shutters that allow excitation light to pass 
alternately though 10-nm bandpass filters centered at 360 and 385 nm. Emitted fluorescence was 
collected at 510 nm by using a Sony CCD camera interfaced to a COMPIX image analysis 
station. After acquisition of baseline fluorescence values for approximately 2 minutes, DNP-
BSA was added by pipette, and fluorescence intensities collected for a further 6 to 8 minutes. 
Data were corrected for background, and average ratio values for each cell in a field were 
calculated for user-defined areas within each cell. Average ratio values were converted to 
[Ca2+]i on the basis of calibration solutions containing maximal and minimal 
Ca2+ concentrations.21 Each experiment provided time-resolved analysis of Ca2+ levels for 4 to 
15 individual cells within a single field of view. 
 
Lyn and Syk phosphorylation 
 
Negatively selected flow-sorted basophils (≥93% pure) were acid stripped and primed as above. 
After 2 minutes of activation, cells were lysed in 400 μL of 50 mmol/L TRIS (pH 7.5), 150 
mmol/L NaCl, 1% Brij, 1 mmol/L sodium orthovanadate, and 1 μg/mL each of antipain, 
leupeptin, aprotinin, and phenylmethylsulfonyl fluoride (PMSF; lysis buffer) and incubated for 
10 minutes on ice. Immune complexes were generated by incubating clarified supernatants with 
anti-Lyn or anti-Syk preadsorbed to protein A-Sepharose beads (Pharmacia, Uppsala, Sweden), 
as previously described.22 The proteins were separated by SDS-PAGE and transferred to 
nitrocellulose sheets, and phosphoproteins were identified by using anti-PY immunoblotting with 
enhanced chemiluminescence detection reagents (ECL, Amersham Corp), as previously 
described.18 After probing with anti-PY antibody, blots were stripped for 30 minutes with 100 
mmol/L 2-mercaptoethanol, 2% SDS (wt/vol), and 0.5 mol/L TRIS-HCl (pH 6.8) at 50°C and 
reprobed with antikinase antibody (1 μg/mL). 
 
Identifying phosphatases 
 
Negatively selected flow-sorted basophils (2-5 × 105 cells/condition), KU812 human basophil–
like cells (ATCC), and HMC-1 human mast cell–like cells (generously provided by J. H. 
Butterfield, Mayo Medical School) were lysed by means of incubation on ice for 10 minutes in 
0.1 mL of lysis buffer, and insoluble material was removed by centrifugation at 10,000g for 5 
minutes. Proteins were separated by 10% PAGE by using 1 × 105 cell equivalents per lane or 10 
to 20 μg/lane and transferred to nitrocellulose, and phosphatases were identified by using 
Western blotting with antibodies to either SHP-1, SHP-2, or SHIP (1 μg/mL) at 4°C in PBS-BSA 
followed by enhanced chemiluminescence detection. 
 
Partitioning of SHP-1 between cytosol and membranes 
 
Negatively selected basophils (2-5 × 105 cells/condition) were suspended at 3 × 107 cells/mL in 
hypotonic lysis buffer (20 mmol/L TRIS [pH 7.5], 5 mmol/L EDTA, 5 mmol/L ethyleneglycol-
bis-(β-aminoethylether)-N,N,N′,N′-tetraacetic acid, 5 mmol/L dithiothreitol, 1 mmol/L PMSF, 
and 100 μg/mL each of leupeptin, aprotinin, and antipain).23 The cells were lysed by placing the 
tubes at –70°C for 15 minutes and then thawing to 4°C. Debris and nuclei were removed by 
centrifugation at 500g at 4°C. The remaining supernatants were centrifuged at 100,000g for 10 
minutes at 4°C. The supernatant (cytosolic) and pellet (membrane) fractions from high-speed 
centrifugations were resuspended directly in 2× or 1× lysis buffer, respectively, and analyzed for 
the presence of SHP-1, SHP-2, and SHIP by using SDS-PAGE and Western blotting, as 
described above. The ECL films from these experiments were scanned and converted to digital 
format. The translocation of SHP-1 was calculated as the percentage found in the cytosol or 
membrane fraction for each cross-linking condition divided by the sum of the cytosol and 
membrane fraction from unstimulated cells. 
 
Cell lysate adsorption to ITIM peptides 
 
Negatively selected basophils (1.5-2.0 × 105 cells/condition) were lysed in 250 μL of NP-40 lysis 
buffer (150 mmol/L NaCl, 10 mmol/L TRIS, 1% Nonidet P-40, 10 mmol/L Na4P2O7, 2 mmol/L 
Na3VO4, 1 mmol/L PMSF, 5 mmol/L NaF, 0.4 mmol/L EDTA, and 10 μg/mL each of leupeptin, 
aprotinin, and antipain). Portions (100 μL) of the clarified lysate were incubated for 30 minutes 
at 4°C with 100 μL of agarose-immobolized streptavidin (Pierce, Milwaukee, Wis) plus 5 μg of 
synthetic biotinylated nonphosphorylated or tyrosine-phosphorylated peptides with the FcγRIIB 
ITIM sequence KGGGAENTIT(p)YSLLKH (Macromolecular Resources, Fort Collins, Colo). 
After the incubation, the lysate-bead mixtures were centrifuged at 10,000g for 1 minute, and the 
beads were resuspended in 2× sample buffer and analyzed with SDS-PAGE and Western 
blotting. 
 
 
 
Fig. 1. A, Membrane expression of FcγRII on human basophils. Percoll-enriched basophils (55% purity) were 
incubated with mouse antibodies to CD16 (FcγRIII), CD32 (FcγRII), or CD64 (FcγRI) followed by FITC-labeled 
goat anti-mouse IgG antibodies and flow cytometry. An irrelevant IgG1 was substituted for the CD antibodies as a 
negative control. Monoclonal antibody 22E7, which binds the FcϵRI α chain, was the positive control. B, Human 
basophils bind mouse anti-DNP IgG. Acid-stripped basophils (43% purity) were incubated with a series of DNP-
specific mouse mAbs followed by FITC-conjugated anti-mouse antibodies and flow cytometry. Monoclonal 
antibody 3B5 (IgG2b), but not two other DNP-specific antibodies (both IgG1; not shown), showed consistent 
binding to basophil FcγRII. C, Expression of FcγRII transcripts in human basophils. Top, RNA from highly purified 
basophils (99.9% pure) or peripheral blood leukocytes (PBL) was reverse transcribed, and FcγRII transcripts were 
selectively amplified. Products were separated on 2% agarose gels and detected by using ethidium bromide staining. 
Actin-specific primers were used as positive controls, and reaction mixtures with primers only (no RNA) were used 
as negative controls. FcγRIIA- and FcγRIIB-specific primers amplified products of 796 and 754 bp, respectively, 
whereas actin primers amplified a product of 627 bp. Bottom,Southern blotting performed with a digoxygenin-UTP–
specific probe recognizing all FcγRII isoforms confirmed the PCR data. The results are representative of studies 
with two separate donors. 
Statistical analysis 
 
Statistical analysis was performed by using Graphpad Prism software (San Diego, Calif). Data 
sets were tested for significant differences by using the paired t test. A P value of less than .05 
was considered to be statistically significant. 
 
Results 
 
Identification of FcγRs on human basophils 
 
The results in Fig 1, A , show that human basophils react strongly with the pan anti-FcγRII mAb 
AT10, weakly with the anti-FcγRIIA-specific mAb IV.3, and not at all with antibodies to CD64 
(FcγRI) or CD16 (FcγRIII). 
 
The results in Fig 1, B , show a strong peak of binding of the DNP-specific IgG2b mAb 3B5 to 
acid-stripped human basophils. In contrast, several other anti-DNP mAb isotypes bound weakly 
and variably to basophils (not shown). 3B5 was selected to prime FcγRII for antigen-mediated 
cross-linking. 
 
The results of RT-PCR analysis, illustrated in Fig 1, C , show that human basophils contain 
transcripts for the ITIM-containing FcγRII isoform FcγRIIB and for the ITAM-containing 
FcγRII isoform FcγRIIA. No transcripts for FcγRIIC were detected in these cell preparations. 
The intensity of the basophil FcγRIIB band suggests that it is the predominant isoform expressed 
on human basophils. 
 
FcγRII/FcϵR1 costimulation inhibits FcϵRI-dependent human basophil degranulation 
 
Fig 2, A , shows that no secretion is induced by simply priming Percoll-enriched basophils with 
DNP-specific IgE or IgG or by cross-linking anti-DNP IgG-FcγRII complexes with polyvalent 
DNP-BSA. 
 
Cross-linking anti-DNP IgE-FcϵRI complexes with DNP-BSA induces histamine release. In 5 
separate experiments costimulating anti-DNP IgE–primed FcϵRI and anti-DNP IgE–primed 
FcγRII with DNP-BSA reduced FcϵRI-mediated secretion by an average of 43% (± 7%). 
 
FcγRII/FcϵR1 costimulation inhibits FcϵR1-mediated IL-4 production 
 
Cross-linking anti-DNP IgE-FcϵRI complexes with DNP-BSA for 4 hours induces IL-4 
production and release (Fig 2, B ). In 3 experiments costimulating anti-DNP IgE–primed FcϵRI 
and anti-DNP IgE–primed FcγRII with DNP-BSA reduced FcϵRI-mediated IL-4 release by an 
average of 36% (± 12%). 
 
 
 
Fig. 2. FcγRII/FcϵR1 costimulation inhibits FcϵR1-mediated basophil degranulation and IL-4 
production. A, Percoll-enriched acid-stripped basophils (20%-35% purity) were incubated with anti-DNP IgE (10 
μg/mL), anti-DNP IgG2b (10 μg/mL), or both antibodies (priming). Histamine release into the medium was 
measured after stimulating the cells with 0.01 μg/mL DNP-BSA for 45 minutes. Results are the average of 5 
separate experiments (± SEM). B, Percoll-enriched acid-stripped basophils (15%-51% purity) were primed as 
in A and incubated with or without 0.005 μg/mL DNP-BSA for 4 hours, and supernatants were assayed for IL-4 
release. Results are the average of 3 separate experiments (± SEM). Asterisks represent values significantly reduced 
(A, P = .012; B, P = .029) when comparing cells primed with IgE alone with cells primed with IgE plus 
IgG. C, Inhibition of histamine release by costimulation is not due to competition for antigen. Percoll-enriched acid-
stripped basophils (15%-25% purity) were incubated for 2 hours with anti-NP IgE (10 μg/mL), anti-DNP IgG2b (10 
μg/mL), or with both antibodies. Histamine release was measured after stimulating the cells with mixtures of NIP-
BSA and DNP-BSA for 45 minutes. Results are the average of two separate experiments (± SEM). 
 
FcγRII/FcϵRI costimulation does not reduce signaling by lowering the availability of antigen to 
FcϵRI 
 
We considered the possibility that costimulation reduces FcϵRI signaling as the result of 
competition between two anti-DNP–primed receptors for the same antigen. The results in Fig 
2, C , show that this is probably not the case. FcϵRI and FcγRII were primed respectively with 
antibodies specific for NP (using anti-NP IgE) or DNP (using anti-DNP IgG). Cells were then 
challenged alone or with combinations of the two antigens. DNP-BSA alone caused no secretion 
(data not shown). NIP-BSA alone induced secretion from anti-NP IgE–primed cells. In dually 
primed cells, adding DNP-BSA to stimulate FcγRII reduced the amount of FcϵRI-mediated 
secretion that could be induced by NIP-BSA by up to 50%. Thus the inhibition of FcϵRI 
signaling by FcγRII/FcϵRI costimulation occurs whether the two receptors are cross-linked by 
the same or different antigens. 
 
 
Fig. 3. FcγRII/FcϵR1 costimulation inhibits FcϵR1-mediated Ca2+ influx in human basophils. Percoll-enriched acid-
stripped basophils (61% purity) were placed on coverslips and primed as in Fig 2. After fura-2 loading, the cells 
were placed on the microscope stage and challenged with 0.01 μg/mL DNP-BSA. Each plot represents the 
Ca2+ response of 3 representative cells. The total number of cells examined in 3 separate experiments and the SD of 
both the lag time to response and the integral of the response over 200 seconds after the initial antigen-stimulated 
increase in [Ca2+]I are noted for two of the 3 conditions. Differences were significant at a P value of less than .01 
(lag time) and a P value of less than .001 (average integral), determined by using the unpaired t test with Welch's 
correction. 
 
FcγRII/FcϵR1 costimulation reduces FcϵRI-mediated Ca2+mobilization 
 
Fluorescence ratio imaging microscopy was used to measure the effects of FcγRII and FcϵR1 
costimulation on intracellular Ca2+ concentrations ([Ca2+]i). Cross-linking anti-DNP IgE–primed 
FcϵRI with DNP-BSA leads, after a lag, to a rapid increase in intracellular Ca2+ levels (Fig 3, A ). 
 
The Ca2+ spike is followed by a sustained elevation in Ca2+ levels (ie, the Ca2+ plateau). In the 3 
experiments reported here, the lag from antigen addition to anti-DNP IgE–primed cells to FcϵRI-
mediated Ca2+ influx was around 21 seconds. The magnitude of the response, estimated by 
integrating Ca2+ concentrations over 200 seconds after the initial Ca2+spike,21 was around 26 
μmol/L per second. No increase in intracellular Ca2+ concentrations was detected in response to 
antigen in cells primed with anti-DNP IgG alone (Fig 3, B ). When cells were primed with both 
DNP-specific IgE and IgG before antigen challenge, the lag time from antigen addition to the 
initial rise in [Ca2+] was approximately doubled, and the integated Ca2+ response was markedly 
diminished (Fig 3, C ). 
 
 
Fig. 4. FcγRII/FcϵR1 costimulation inhibits FcϵRI-mediated Syk phosphorylation. Percoll-enriched negatively 
selected basophils (93% purity) were acid stripped, primed as in Fig 2, and challenged for 2 minutes with 0.01 
μg/mL DNP-BSA. Cells were lysed, and Lyn (A) or Syk (B) was immunoprecipitated from the clarified lysates. In 
these experiments immunoprecipitates from 4.3 to 9.4 × 105 basophils were analyzed by Western blotting with anti-
phosphotyrosine antibodies (PY) , followed by anti-Syk or anti-Lyn antibodies. The results are representative of two 
separate experiments. 
 
FcγRII/FcϵR1 costimulation inhibits FcϵRI-mediated Syk phosphorylation 
 
Lyn and Syk were immunoprecipitated from lysates of variously activated cells, and the immune 
complexes were resolved by means of SDS-PAGE and probed with antiphosphotyrosine 
followed by antikinase antibodies. As shown in Fig 4, Lyn, but not Syk, is tyrosine 
phosphorylated in resting basophils. 
 
 
Fig. 5. A, Human basophils express SHP-1, SHP-2, and SHIP. Negatively selected flow-sorted basophils (>95% 
purity), KU812 cells, or HMC-1 cells were lysed and proteins (13 μg/lane) were separated by using SDS-PAGE and 
Western blotted with anti-SHP-1, anti-SHP-2, or anti-SHIP antibodies. Results shown are representative of two 
separate experiments. SHIP was calculated to be between 140 and 145 kd. B, SHP-1 is translocated to the membrane 
after FcγRII cross-linking. Highly purified basophils (97% purity; 2-5 × 105 cells/condition) were primed as in Fig 
2 and challenged for 2 minutes with 0.01 μg/mL DNP-BSA. Membrane and cytosolic fractions were separated by 
SDS-PAGE and immunoblotted with anti-SHP-1 or anti-SHP-2 antibodies. Results shown are representative of 5 
(SHP-1) or 3 (SHP-2) separate experiments. The bottom panel shows the amount of SHP-1 in the cytosol or 
membrane expressed as a percentage of the sum of SHP-1 in resting cells. C, The FcγRIIB phospho-ITIM peptide 
selects SHP-1 from human basophil lysates. Lysates of negatively selected flow-sorted basophils (96% purity) were 
incubated with biotinylated nonphosphorylated or tyrosine-phosphorylated FcγRIIB ITIMs plus agarose-
immobilized streptavidin. After 30 minutes, the beads were washed and analyzed by SDS-PAGE and Western 
blotting. Whole cell lysates were used as a positive control for each experiment (data not shown). 
 
As reported previously,18 cross-linking anti-DNP IgE–primed FcϵRI with DNP-BSA induces a 
substantial tyrosine phosphorylation of Lyn and Syk. The amount of Syk tyrosine 
phosphorylation is markedly reduced in IgE plus IgG–primed cells, when DNP-BSA stimulates 
both FcγRII and FcϵRI. Lyn phosphorylation appeared to be very similar between IgE-primed, 
IgG-primed, or dually primed and activated cells (Fig 5, B ). 
 
Human basophils express SHP-1, SHP-2, and SHIP 
 
Lysates of human basophils were probed for the protein tyrosine phosphatases SHP-1 and SHP-2 
and the polyphosphoinositide 5-phosphatase SHIP. As shown in Fig 5, A , SHP-1 and SHP-2 
were both readily detected in human basophils. SHIP was also present but required longer 
exposure time to the ECL reagents for detection. 
 
FcγRII cross-linking induces the translocation of SHP-1 from cytosol to membranes 
 
The results in Fig 5, B , show that SHP-1 is mainly in the cytosolic fraction of IgE- and IgG-
primed human basophils. Cross-linking FcϵR1 on anti-DNP IgE–primed cells with DNP-BSA 
does not affect the partitioning of SHP-1 between cytosol and membranes. In contrast, a 
substantial proportion of SHP-1 is membrane associated when FcγRII and FcϵR1 are 
costimulated by the addition of DNP-BSA to cells sensitized with anti-DNP IgE plus anti-DNP 
IgG. Remarkably, simply cross-linking anti-DNP IgG–primed FcγRII with DNP-BSA also 
recruits SHP-1 from the cytosol to the membrane. SHP-2 remained in the cytosolic fraction 
under all conditions. In these experiments SHIP was not detected in either cytosol or membrane 
fractions, very likely reflecting excess dilution of inherently scarce proteins during cell 
fractionation. 
 
FcγRIIB phospho-ITIM peptide selectively adsorb SHP-1 from human basophil lysates 
 
Basophil lysates were incubated with biotinylated peptides corresponding to the murine FcγRIIB 
sequence KTEAENTITYSLLK (highly homologous to the human sequence)24 in both the 
phosphorylated and nonphosphorylated forms, and the peptides were recovered by incubation 
with streptavidin-Sepharose beads and analyzed by using SDS-PAGE. Fig 5, C , shows that the 
FcγRIIB phospho-ITIM specifically adsorbs SHP-1 from basophil lysates. No SHP-1 is adsorbed 
to the nonphosphorylated FcγRIIB ITIM. 
 
Discussion 
 
The ability of the ITIM-containing IgG receptor FcγRIIB to act as a negative regulator of ITAM-
containing immunoreceptors was recognized initially through studies of the antigen receptor of B 
cells and was subsequently extended to studies of T-cell activation through the TCR.4 FcγRIIB 
was first implicated in the negative regulation of FcϵR1-mediated signaling by Daeron et al.25 
These investigators sensitized acid-stripped basophils with murine IgE and activated them with 
anti-mouse Ig antibodies with or without preincubation with anti-CD32 mAb; FcγRII and FcϵR1 
costimulation led to inhibition of FcϵRI-induced histamine release. Daeron et al26 extended their 
analysis of FcγRII/FcϵR1 crosstalk by developing stably transfected RBL-2H3 cells expressing 
murine and human FcγRIIB isoforms. In the rat model system they confirmed that the 13-amino 
acid ITIM sequence in the human FcγRIIB was necessary to inhibit FcϵR1-mediated secretion 
and raised the possibility that allergen immunotherapy may work in part by promoting negative 
signaling from FcγRIIB to FcϵRI. These landmark studies left open several critical issues, 
including the identity of FcγRII isoforms expressed on human basophils and evidence that co–
cross-linking IgE and IgG directed at the same polyvalent antigen downregulates the FcϵR1-
mediated activation of human cells. 
 
There are multiple FcγRII isoforms, representing the products of 3 distinct genes.4 FcγRIIA 
occurs in both a transmembrane form with an ITAM and a soluble form that results from 
alternative splicing. Three FcγRIIB isoforms, all transmembrane proteins with cytoplasmic 
ITIMs, arise by means of alternative splicing. FcγRIIC is a single membrane-spanning receptor 
that also carries a cytoplasmic ITAM. Natural killer cells express 4 different transcripts of the 
gene encoding FcγRIIC.20 Here we have confirmed that human basophils express CD32 
(FcγRII), but not CD16 (FcγRIII) or CD64 (FcγRI).27, 28, 29 Our PCR results establish that human 
basophils contain transcripts for both the ITIM-containing FcγRIIB and the ITAM-containing 
FcγRIIA. 
 
We report that co–cross-linking of anti-DNP IgG–primed FcγRII and anti-DNP IgE–primed 
FcϵRI on human basophils with specific antigen (DNP-BSA) inhibits FcϵRI-induced 
degranulation and also inhibits FcϵRI-mediated IL-4 production. These results provide the first 
demonstration of antigen-specific downregulation of FcϵRI-mediated signaling though 
FcγRII/FcϵRI costimulation on human basophils. FcϵRI-induced degranulation is also inhibited 
when anti-DNP IgG–primed FcγRII and anti-NP IgE–primed FcϵRI on human basophils are 
costimulated with separate antigens (DNP-BSA and NIP-BSA). Thus negative signaling from 
FcγRII to FcϵRI can occur when the receptors are co-stimulated with separate antigens, as well 
as when they are co–cross-linked with the same antigen. For this reason, although the majority of 
experiments reported here were performed under co–cross-linking conditions, we describe our 
experimental conditions as costimulation. 
 
In RBL-2H3 cells and human basophils FcϵRI-mediated degranulation and IL-4 production 
depend on the Ins(1,4,5)P3-dependent release of Ca2+from intracellular stores and on the 
subsequent sustained influx of Ca2+from the medium by both capacitative and receptor-coupled 
pathways.21, 30 We resolved the two phases of the Ca2+ mobilization response by using ratio 
imaging microscopy. FcγRII/FcϵRI costimulation extends the lag time from FcϵRI cross-linking 
to the Ca2+ spike response, which reflects the release of Ca2+ stores, and also reduces the 
magnitude of the Ca2+ plateau, which is attributed principally to Ca2+ influx. Previous studies 
examiningFcγ-RII/BCR co–cross-linked B cells reported premature termination of Ca2+ influx, 
which is sometimes associated with a reduced Ca2+ spike response but not an increased delay to 
the spike response.31, 32, 33, 34 The difference is unexplained but may simply reflect the poorer 
time resolution of population-averaged spectrofluorometric assays in comparison with single cell 
microscopic assays of Ca2+ mobilization. Alternatively, the differences may reflect distinct 
signaling properties of B cells and basophils. 
 
Phosphorylation of the tyrosine kinase Syk is a key event linking FcϵR1 cross-linking to 
downstream signaling pathways in rodent mast cells22, 35, 36 and human basophils.18, 37 Here we 
show a modest level of basal Lyn phosphorylation and little or no tyrosine-phosphorylated Syk 
in either resting cells or in cells where only FcγRII was cross-linked. FcϵR1 cross-linking 
resulted in increased Lyn and Syk phosphorylation. Syk, but not Lyn, phosphorylation was 
markedly decreased by co-stimulating FcγRII and FcϵR1. The functional significance of 
changing Lyn phosphorylation is difficult to interpret because this Src family kinase is 
phosphorylated on both inhibitory and stimulatory sites. On the other hand, Syk has no inhibitory 
tyrosine phosphorylation sites, and therefore its increased tyrosine phosphorylation is a strong 
indicator of its increased catalytic activity.4 Our data differ from the results of Malbec et al,38 
who found in transfected RBL-2H3 cells that Syk phosphorylation was unaffected by 
FcγRII/FcϵR1 co–cross-linking. The results presented here resemble previous studies in human 
B cells showing reduced levels of Syk tyrosine phosphorylation when FcγRIIB was cross-linked 
to the BCR.31, 32 
 
The results of Western blot analysis established that human basophils express all 3 phosphatases 
previously implicated in negative signaling: SHP-1, SHP-2, and SHIP. Further studies by cell 
fractionation showed that SHP-1 is translocated from the cytosolic to membrane fractions of 
basophils during FcϵR1 and FcγRII costimulation, as well as in response to FcγRII co-cross-
linking alone. Fractionation studies do not identify the membrane-binding sites for SHP-1. 
However, synthetic biotinylated peptides corresponding to the phosphorylated FcγRIIB ITIM 
sequence recruit SHP-1 from basophil lysates. These data implicate phosphorylated FcγRIIB 
ITIM sequences as likely targets for membrane-bound SHP-1. 
 
Several issues remain to be explored. First, published data link inhibitory signaling from FcγRII 
to the BCR or to the FcϵRI of transfected RBL-2H3 cells principally to the interaction of SHIP 
with the phospho-ITIMs of FcγRIIB.38, 39, 40, 41, 42 It remains possible that SHIP contributes 
importantly to the inhibition of FcϵRI signaling by costimulating FcγRII in human basophils and 
that more sensitive detection methods will reveal its involvement. On the other hand, SHP-1 is 
strongly implicated in the inhibitory signaling that occurs from the ITIM-containing receptors 
KIR and CD22 to the BCR and from the ITIM-containing receptors gp49B and PIR-B to the 
FcϵR1.33, 34, 35, 41, 43, 44, 45, 46 Second, it is unclear whether the reduced phosphorylation of Syk 
caused by FcϵRI/FcγRII costimulation results from the dephosphorylation of FcϵRI phospho-
ITAMs, which could reduce Syk recruitment and activation, or from the dephosphorylation of 
Syk itself. A direct association of Syk and SHP-1 has been demonstrated previously in B cells.47 
In addition to Syk,47, 48 there is a growing list of receptor-associated tyrosine kinases that are 
inhibited by SHP-1,49, 50, 51 raising the possibility that Syk may not be the only target of negative 
regulation in human basophils. Finally, we have not yet addressed the mechanism of SHP-1 
recruitment induced by FcγRII cross-linking alone in human basophils. It is possible that FcγRII 
cross-linking on basophils may generate hybrid complexes (FcγRIIB plus FcγRIIA) in which the 
ITAM-containing FcγRIIA may recruit and activate tyrosine kinases that in turn phosphorylate 
FcγRIIB ITIMs, creating membrane-binding sites for SHP-1. 
 
In summary, Syk phosphorylation and positive signaling through the high-affinity IgE receptor 
FcϵRI on human basophils can be inhibited by costimulating the low-affinity IgG receptor 
FcγRII. We hypothesize that this negative signaling from FcγRII to FcϵRI occurs at least in part 
by the recruitment of SHP-1 to the FcγRIIB ITIM, positioning it to block or reverse the 
phosphorylation and activation of Syk needed to couple FcϵRI crosslinking to downstream 
responses. 
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